Analysen von Fabian Smeets
| 08.11.12 | RELX NV (ex Reed Elsevier) buy | ING | |
| 07.11.12 | Wolters Kluwer buy | ING | |
| 18.09.12 | K+S buy | ING | |
| 07.09.12 | WACKER CHEMIE buy | ING | |
| 04.09.12 | K+S buy | ING | |
| 03.09.12 | Novozymes A-S (B) buy | ING |
| 08.11.12 | RELX NV (ex Reed Elsevier) buy | ING | |
| 07.11.12 | Wolters Kluwer buy | ING | |
| 18.09.12 | K+S buy | ING | |
| 07.09.12 | WACKER CHEMIE buy | ING | |
| 04.09.12 | K+S buy | ING | |
| 03.09.12 | Novozymes A-S (B) buy | ING |